Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma
The transcription factor MYBL2 is widely expressed in proliferating cells. Aberrant expression of MYBL2 contributes to tumor malignancy and is associated with poor patient prognosis. However, the downstream transcriptional network that mediates its oncogenic properties remains elusive. In the presen...
Main Authors: | Feiliang Zhong, Jia Liu, Chang Gao, Tingting Chen, Bo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.816070/full |
Similar Items
-
Studies of liver tissue identify functional gene regulatory elements associated to gene expression, type 2 diabetes, and other metabolic diseases
by: Marco Cavalli, et al.
Published: (2019-04-01) -
Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers
by: Zekun Xin, et al.
Published: (2022-01-01) -
Comprehensive assessment of differential ChIP-seq tools guides optimal algorithm selection
by: Thomas Eder, et al.
Published: (2022-05-01) -
Impact of artefact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data.
by: Thomas Samuel Carroll, et al.
Published: (2014-04-01) -
Understanding gene regulatory mechanisms by integrating ChIP-seq and RNA-seq data: statistical solutions to biological problems
by: Claudia eAngelini, et al.
Published: (2014-09-01)